FSCPX structure
|
Common Name | FSCPX | ||
|---|---|---|---|---|
| CAS Number | 156547-56-7 | Molecular Weight | 506.54700 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H27FN4O6S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FSCPXFSCPX is a potent and selective irreversible antagonist of A1 adenosine receptor (A1AR), with low nanomolar potency for binding to the A1AR. FSCPX could modifies the effect of NBTI, a nucleoside transport inhibitor, by reducing the interstitial adenosine level in the guinea pig atrium[1][2]. |
| Name | 3-(8-cyclopentyl-2,6-dioxo-1-propyl-7H-purin-3-yl)propyl 4-fluorosulfonylbenzoate |
|---|---|
| Synonym | More Synonyms |
| Description | FSCPX is a potent and selective irreversible antagonist of A1 adenosine receptor (A1AR), with low nanomolar potency for binding to the A1AR. FSCPX could modifies the effect of NBTI, a nucleoside transport inhibitor, by reducing the interstitial adenosine level in the guinea pig atrium[1][2]. |
|---|---|
| Related Catalog | |
| Target |
A1AR[1] |
| In Vitro | FSCPX irreversibly blocks the binding of [3H]-8-cyclopentyl-1,3dipropylxanthine ([3H]DPCPX), with an IC50 of 11.8±3.2 nM in DDT1 MF2 cells[1]. |
| References |
| Molecular Formula | C23H27FN4O6S |
|---|---|
| Molecular Weight | 506.54700 |
| Exact Mass | 506.16400 |
| PSA | 141.50000 |
| LogP | 3.94000 |
| Vapour Pressure | 3.28E-21mmHg at 25°C |
| InChIKey | XJLGXHIRSHTRPQ-UHFFFAOYSA-N |
| SMILES | CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCCOC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O |
| Safety Phrases | 22-24/25 |
|---|
| Lopac-F-7927 |
| HMS3261F15 |
| FSCPX |
| FSCPX xanthine |
| 8-Cyclopentyl-N3-[3-(4-(fluorosulfonyl)benzoyloxy)propyl]-N1-propylxanthine |